NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/astrazeneca-plc-l ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pacira-biosciences-inc- ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innovative Industrial Properties, Inc. ("Innovative Industrial Properties" or the "Company") (NYSE: IIPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innovative Industrial Properties investors who were adversely affected by alleged securities fraud between February 27, 2024 and December 19, 2024. Follow the link below to get more information and be contacted by ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2, 2023 and October 30, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/regene ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. ("ESSA Pharma Inc." or the "Company") (NASDAQ: EPIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who were adversely affected by alleged securities fraud between December 12, 2023 and October 31, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/essa-p ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, 2024 and December 6, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/revance-therap ...

On Thursday, Neurocrine Biosciences Inc. NBIX reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a year ago, beating the consensus of $1.56.The company reported sales of $627.7 million compared to $515.2 million a year ago, missing the consensus of $628.99 million.Ingrezza fourth quarter and fiscal 2024 net product sales were $615 million and $2.3 billion, respectively.Also Read: Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan RightsIngrezza fourth ...

Pinterest, Inc. PINS shares are trading higher on Friday.Yesterday, Pinterest reported fourth-quarter revenue of $1.15 billion, beating estimates of $1.14 billion, according to Benzinga Pro. The company reported fourth-quarter earnings of 56 cents per share, missing analyst estimates of 65 cents per share.Pinterest expects first-quarter revenue to be in the range of $837 million to $852 million.Here are the analysts’ take on the stock:BofA Securities analyst Justin Post reiterated the Buy rating on the stoc ...

CSL Limited CSLLY and uniQure Inc QURE announced the four-year results from the pivotal HOPE-B study confirming the long-term durability and safety of a one-time infusion of Hemgenix (etranacogene dezaparvovec-drlb) for adults hemophilia B patients.The data showed that through four years, Hemgenix continues to deliver elevated and sustained factor IX activity levels, can offer long-term and greater bleed protection compared to prophylactic treatment, can eliminate the need for routine factor IX prophylaxis, ...

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Transocean Ltd. ("Transocean Ltd." or the "Company") (NYSE: RIG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Transocean Ltd. investors who were adversely affected by alleged securities fraud between October 31, 2023 and September 2, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/transocean-l ...